Vesitirim™ in Men Postmarketing Observational Study

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Lower Urinary Tract Symptoms (LUTS)Overactive Bladder (OAB)

Interventions

DRUG

Vesitirim™ (Solifenacin)

Oral

Trial Locations (5)

Site: 1 - St James Hopsital, Dublin

Site: 5 - Beaumont Hospital, Dublin

Site: 4 - Tallaght Hospital, Dublin

Site 2 - Mercy University Hospital, Cork

Site: 3 - Sligo General Hospital, Sligo

All Listed Sponsors

lead

Astellas Pharma Europe Ltd.

INDUSTRY

NCT01639794 - Vesitirim™ in Men Postmarketing Observational Study | Biotech Hunter | Biotech Hunter